Matches in SemOpenAlex for { <https://semopenalex.org/work/W1633992964> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W1633992964 abstract "Yttrium-90 90Y) ibritumomab tiuxetan is an immunotherapeutic agent that has recently been approved for the treatment of relapsed or refractory low-grade, follicular, or CD20+ transformed non-Hodgkin’s lymphoma (NHL). 90Y-ibritumomab tiuxetan has delivered highly encouraging responses in clinical studies and represents a major advance in the management of patients with difficult forms of NHL. This agent is notable for its emission of b radiation only, which minimizes or eliminates the need for radiation safety precautions normally associated with radiopharmaceuticals and permits treatment to be carried out in an outpatient setting. Moreover, dosimetry is not required prior to therapy for approved usage in the European Union, and preparation of the radiolabeled monoclonal antibody is straightforward and easily learned. Traditionally, nuclear medicine physicians have been solely responsible for the management of patients undergoing radiotherapy, but logistic, patient selection, and haematological safety considerations call for a multidisciplinary team approach to optimize outcomes with 90Y-ibritumomab tiuxetan. The team should include the haemato-oncologist or haematologist, immunopathologist, clinical nurse specialist, nuclear medicine physician, radiopharmacist, radiation protection specialist, and other nurses, junior and administrative staff, as appropriate. The team approach draws on a wide range of specialist skills and early data from a major UK institution show that treatment benefits are maximised when treatment is administered on a collaborative basis. Thus, 90Y-ibritumomab tiuxetan represents a significant therapeutic advance, and provides new opportunities for optimizing therapeutic outcomes through the multidisciplinary approach to patient care." @default.
- W1633992964 created "2016-06-24" @default.
- W1633992964 creator A5044912710 @default.
- W1633992964 date "2009-06-17" @default.
- W1633992964 modified "2023-09-28" @default.
- W1633992964 title "United for success against non-Hodgkin's lymphoma: role and responsibilities of the nuclear medicine department" @default.
- W1633992964 cites W2033903037 @default.
- W1633992964 cites W2035394986 @default.
- W1633992964 cites W2054823183 @default.
- W1633992964 cites W2078052929 @default.
- W1633992964 cites W2080416356 @default.
- W1633992964 cites W2093620219 @default.
- W1633992964 cites W2101141816 @default.
- W1633992964 cites W2107466475 @default.
- W1633992964 cites W2107990794 @default.
- W1633992964 cites W2110646221 @default.
- W1633992964 cites W2164532418 @default.
- W1633992964 cites W2417081786 @default.
- W1633992964 cites W1603051829 @default.
- W1633992964 doi "https://doi.org/10.4081/hmr.v1i5.642" @default.
- W1633992964 hasPublicationYear "2009" @default.
- W1633992964 type Work @default.
- W1633992964 sameAs 1633992964 @default.
- W1633992964 citedByCount "0" @default.
- W1633992964 crossrefType "journal-article" @default.
- W1633992964 hasAuthorship W1633992964A5044912710 @default.
- W1633992964 hasConcept C126322002 @default.
- W1633992964 hasConcept C144024400 @default.
- W1633992964 hasConcept C159654299 @default.
- W1633992964 hasConcept C19527891 @default.
- W1633992964 hasConcept C203014093 @default.
- W1633992964 hasConcept C22467394 @default.
- W1633992964 hasConcept C2776146153 @default.
- W1633992964 hasConcept C2777058707 @default.
- W1633992964 hasConcept C2778515704 @default.
- W1633992964 hasConcept C2779338263 @default.
- W1633992964 hasConcept C2780920918 @default.
- W1633992964 hasConcept C36289849 @default.
- W1633992964 hasConcept C509974204 @default.
- W1633992964 hasConcept C542903549 @default.
- W1633992964 hasConcept C71924100 @default.
- W1633992964 hasConceptScore W1633992964C126322002 @default.
- W1633992964 hasConceptScore W1633992964C144024400 @default.
- W1633992964 hasConceptScore W1633992964C159654299 @default.
- W1633992964 hasConceptScore W1633992964C19527891 @default.
- W1633992964 hasConceptScore W1633992964C203014093 @default.
- W1633992964 hasConceptScore W1633992964C22467394 @default.
- W1633992964 hasConceptScore W1633992964C2776146153 @default.
- W1633992964 hasConceptScore W1633992964C2777058707 @default.
- W1633992964 hasConceptScore W1633992964C2778515704 @default.
- W1633992964 hasConceptScore W1633992964C2779338263 @default.
- W1633992964 hasConceptScore W1633992964C2780920918 @default.
- W1633992964 hasConceptScore W1633992964C36289849 @default.
- W1633992964 hasConceptScore W1633992964C509974204 @default.
- W1633992964 hasConceptScore W1633992964C542903549 @default.
- W1633992964 hasConceptScore W1633992964C71924100 @default.
- W1633992964 hasIssue "5" @default.
- W1633992964 hasLocation W16339929641 @default.
- W1633992964 hasOpenAccess W1633992964 @default.
- W1633992964 hasPrimaryLocation W16339929641 @default.
- W1633992964 hasVolume "1" @default.
- W1633992964 isParatext "false" @default.
- W1633992964 isRetracted "false" @default.
- W1633992964 magId "1633992964" @default.
- W1633992964 workType "article" @default.